The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ⅰ open-label dose-escalation study of AL2846 in combination with gemcitabine in patients with locally advanced or metastatic pancreatic adenocarcinoma.
 
Rui Liu
No Relationships to Disclose
 
Ting Deng
No Relationships to Disclose
 
Ming Bai
No Relationships to Disclose
 
Le Zhang
No Relationships to Disclose
 
Tao Ning
No Relationships to Disclose
 
Xia Wang
No Relationships to Disclose
 
Zhi Ji
No Relationships to Disclose
 
Yuchong Yang
No Relationships to Disclose
 
Shaohua Ge
No Relationships to Disclose
 
Hongli Li
No Relationships to Disclose
 
Jingjing Duan
No Relationships to Disclose
 
Yi Ba
No Relationships to Disclose